Text Size

Inaugural Glaucoma 360 a Great Success!

Attendees at the New Horizons Forum
Attendees at the New Horizons Forum

The Glaucoma Research Foundation (GRF) Annual Benefit “Catalyst for a Cure” on February 2, 2012 kicked off the inaugural Glaucoma 360, a three-day series of events making possible a comprehensive view of glaucoma today. All proceeds support GRF research and education programs.

More than 350 attended the benefit gala and dinner held at the historic Palace Hotel in San Francisco, chaired by Nobuko Saito Cleary and Gary Cleary, PharmD, PhD. Mona and Ed Zander hosted the Innovators Circle reception, welcoming major donors, platinum level sponsors, researchers, and other distinguished guests. George A. Cioffi, MD was presented The Innovator’s Award in recognition for his leadership of GRF’s Scientific Advisory Committee and his outstanding contributions to glaucoma research.


In ceremonies at the gala, Nobuko Saito Cleary received the President’s Award from Thomas M. Brunner in recognition of her tireless commitment to raising awareness and support for Glaucoma Research Foundation. The Consul General of Japan, Hiroshi Inomata brought personal greetings from the Prime Minster of Japan, Yoshihiko Noda, and via video Norman Mineta, former United States Secretary of Transportation, offered his congratulations to Nobuko on this special honor.

The 2012 Catalyst Award was presented to Richard L. Lindstrom, MD by GRF Board member Adrienne Graves, PhD for his outstanding contributions to ophthalmology and scientific discovery, and Tonia Rex, PhD, received The Shaffer Prize for Innovative Glaucoma Research. This year’s Visionary Award was presented by Dennis Singleton to Roger McGuinn, co-founder of The Byrds and National Honorary Chairman of the Catalyst for a Cure Campaign. Roger then closed the evening’s program with a private concert.

The following day, GRF launched the New Horizons Forum, co-founded by Adrienne Graves, PhD and Andrew Iwach, MD, to bring together highly respected leaders in medicine, science, business, venture capital, and philanthropy to share the latest advances in glaucoma therapies and research. This meeting fostered important collaborations that broadened our understanding of glaucoma and will ultimately lead to innovative new treatments for patients with glaucoma.

Glaucoma 360 wrapped up with the 16th Annual Glaucoma Symposium CME, designed to update ophthalmologists on key developments and current issues in glaucoma. With more than 300 physicians attending, this is the largest continuing medical education event focused solely on glaucoma in North America. Patients across the county will benefit from the knowledge gained at this symposium related to advances in glaucoma management, medication, and surgical techniques.

GRF is truly grateful for the generous support and dedicated involvement of so many that made these events such a success. Please save the dates for next year’s Glaucoma 360: January 31 to February 2, 2013.

Last reviewed on October 29, 2017

This article appeared in the May 2012 issue of Gleams.


Was this helpful? Yes No